Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Anna Unseld

Once-Daily Tiotropium Respimat® Add-On Therapy Has a Safety Profile Comparable With Placebo in Children and Adolescents

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2017

English

Comparative Responses in Lung Function Measurements With Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis

Pulmonary Therapy

2020

English

Related publications

Tiotropium in Children and Adolescents With Asthma

Annals of Allergy, Asthma and Immunology

English

A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2017

English

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

English

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Pulmonary Pharmacology and Therapeutics

English

Tiotropium Provides Greater Improvements in FEV1 Than an LTRA as Add-On to ICS in Children and Adolescents With Asthma: A Systematic Review

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

New Abilities of Administration of Tiotropium Bromide Using the Aerosol Delivery Device Respimat®

English

Efficacy and Safety of Olodaterol Once Daily Delivered via Respimat® In Patients With GOLD 2–4 COPD: Results From Two Replicate 48-Week Studies

International Journal of COPD

English

Effect of Once-Daily Tiotropium and Olodaterol, Alone and Combined With Exercise Training, on Two Measures of Walking Capacity in Patients With COPD

Chest

Cardiology

Critical Care

Cardiovascular Medicine

Intensive Care Medicine

Pulmonary

Respiratory Medicine

2016

English

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Anna Unseld

Once-Daily Tiotropium Respimat® Add-On Therapy Has a Safety Profile Comparable With Placebo in Children and Adolescents

Comparative Responses in Lung Function Measurements With Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis

Related publications

Tiotropium in Children and Adolescents With Asthma

A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Tiotropium Provides Greater Improvements in FEV1 Than an LTRA as Add-On to ICS in Children and Adolescents With Asthma: A Systematic Review

New Abilities of Administration of Tiotropium Bromide Using the Aerosol Delivery Device Respimat®

Efficacy and Safety of Olodaterol Once Daily Delivered via Respimat&reg; In Patients With GOLD 2&ndash;4 COPD: Results From Two Replicate 48-Week Studies

Effect of Once-Daily Tiotropium and Olodaterol, Alone and Combined With Exercise Training, on Two Measures of Walking Capacity in Patients With COPD

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

Efficacy and Safety of Olodaterol Once Daily Delivered via Respimat® In Patients With GOLD 2–4 COPD: Results From Two Replicate 48-Week Studies